|Draft guidance consultation||30 June 2017 - 11 August 2017|
|Expected publication||January 2018|
|Developer||NICE Clinical Guidelines Team|
- If you have any queries please email MacularDegeneration@nice.org.uk
|15 May 2017||Stakeholder list updated|
|18 April 2017||The consultation dates and publication date for this guideline have been revised.|
|03 March 2017||Committee list updated|
|02 March 2017||Pre-consultation documents released|
|05 January 2017||Committee meeting: 12|
|06 December 2016||Committee meeting: 11|
|24 October 2016||Committee meeting: 10|
|05 September 2016||Committee meeting: 9|
|13 July 2016||Committee meeting: 8|
|24 May 2016||Committee meeting: 7|
|04 September 2015||Committee meeting|
|27 August 2015||Scope published|
|08 May 2015 - 08 June 2015||Draft scope consultation|
|07 September 2015||
The Developer may make a focused call for evidence on specific clinical questions or sub-questions after completing its initial searches. It is able to make a call for evidence at any point during development of the guideline and stakeholders are usually given 4weeks to respond. The Developer will ask all registered stakeholders for this evidence.
The Developer may not issue any calls for evidence for a guideline if the Committee feels it is not necessary.
The Economic plan, review questions and search strategies will be available on the website 5 weeks before the draft guideline consultation starts.
|27 August 2015||
The Committee looks at the evidence and develops the recommendations in the guideline.
|08 June 2015||
Consultation on the draft scope is complete and the scope is being modified in the light of the comments. The final scope will be posted here. It will define what the guideline will cover.
We are in the finalising details for developing the guideline, including the membership of the Committee and timescales.
|08 January 2015||Recruitment for the Guideline Development Group Chair and one member closed on 08/01/2015.|
|22 December 2014||The Internal Development team is currently looking to recruit a Chair and one member for the Guideline Development Group. Please see here for more information.|
|1 December 2014||The referral was received from the Department of Health as part of the Institute's work programme.|
For further information on the guideline development process, please read how we develop NICE guidelines